Memantine May Be Effective for Mild to Moderate Alzheimer's Disease

"Results of a phase III trial of memantine hydrochloride monotherapy in patients with mild to moderate Alzheimer's disease suggest that the drug is effective at all stages of the disease. Lead investigator Nunzio Pomara, MD, a research professor at the Nathan S. Kline Institute at New York University School of Medicine, said, 'This is now our drug of choice in patients who begin to show any mental deterioration.' Dr. Pomara presented the findings at the 9th International Conference on Alzheimer's Disease and Related Disorders."